{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:06:26Z","timestamp":1772118386867,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Korea Healthcare Technology R&D"},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry for Health, Welfare & Family Affairs, Republic of Korea","award":["HI16C1559"],"award-info":[{"award-number":["HI16C1559"]}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.jcyt.2018.04.004","type":"journal-article","created":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T07:19:10Z","timestamp":1529651950000},"page":"820-829","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["The combination of mannitol and temozolomide increases the effectiveness of stem cell treatment in a chronic stroke model"],"prefix":"10.1016","volume":"20","author":[{"given":"Chunggab","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeeheun","family":"Shon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiae","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeong-Taek","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suk Ho","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Hun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nam Keun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7333-0647","authenticated-orcid":false,"given":"Ok Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2018.04.004_bib0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1750-1326-6-11","article-title":"Pathophysiology, treatment, and animal and cellular models of human ischemic stroke","volume":"6","author":"Woodruff","year":"2011","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0015","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1161\/01.STR.23.9.1230","article-title":"Some epidemiological aspects of stroke: mortality\/morbidity trends, age, sex, race, socioeconomic status","volume":"23","author":"Modan","year":"1992","journal-title":"Stroke"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0020","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.nbd.2009.10.003","article-title":"Optimizing the success of cell transplantation therapy for stroke","volume":"37","author":"Bliss","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0025","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7682960","article-title":"Therapy effects of bone marrow stromal cells on ischemic stroke","volume":"2016","author":"Ye","year":"2016","journal-title":"Oxid Med Cell Longev"},{"issue":"Suppl.","key":"10.1016\/j.jcyt.2018.04.004_bib0030","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1038\/nm1064","article-title":"Stem cell therapy for human neurodegenerative disorders-how to make it work","volume":"10","author":"Lindvall","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2015.03.014","article-title":"The potential use of mesenchymal stem cells in stroke therapy\u2013From bench to bedside","volume":"352","author":"Dulamea","year":"2015","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0040","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.stem.2012.02.005","article-title":"Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease","volume":"10","author":"Ranganath","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0045","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.brainres.2008.06.087","article-title":"Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats","volume":"1229","author":"Koh","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0050","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/PAT.0b013e32834ab72d","article-title":"Potential therapeutic applications of mesenchymal stromal cells","volume":"43","author":"Larsen","year":"2011","journal-title":"Pathology"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0055","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/ana.20501","article-title":"Autologous mesenchymal stem cell transplantation in stroke patients","volume":"57","author":"Bang","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0060","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/stem.430","article-title":"A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke","volume":"28","author":"Lee","year":"2010","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0065","first-page":"151","article-title":"Autologous bone marrow stem cell neurotransplantation in stroke patients. An open study","volume":"27","author":"Suarez-Monteagudo","year":"2009","journal-title":"Restor Neurol Neurosci"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0070","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ana.22458","article-title":"Intravenous autologous bone marrow mononuclear cells for ischemic stroke","volume":"70","author":"Savitz","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0075","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.06.011","article-title":"Reparative therapy for acute ischemic stroke with allogeneic mesenchymal stem cells from adipose tissue: a safety assessment: a phase II randomized, double-blind, placebo-controlled, single-center, pilot clinical trial","volume":"23","author":"Diez-Tejedor","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0080","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1161\/01.STR.0000141680.49960.d7","article-title":"Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke","volume":"35","author":"Borlongan","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0085","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3727\/096368914X678337","article-title":"Mannitol-enhanced delivery of stem cells and their growth factors across the blood-brain barrier","volume":"23","author":"Gonzales-Portillo","year":"2014","journal-title":"Cell Transplant"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0090","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.3727\/096368916X690971","article-title":"Breaking the blood-brain barrier with mannitol to aid stem cell therapeutics in the chronic stroke brain","volume":"25","author":"Tajiri","year":"2016","journal-title":"Cell Transplant"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0095","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nm.2399","article-title":"The immunology of stroke: from mechanisms to translation","volume":"17","author":"Iadecola","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0100","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1189\/jlb.1109766","article-title":"Inflammatory mechanisms in ischemic stroke: role of inflammatory cells","volume":"87","author":"Jin","year":"2010","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0105","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neuroscience.2008.02.012","article-title":"The blood-brain barrier is continuously open for several weeks following transient focal cerebral ischemia","volume":"153","author":"Strbian","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0110","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.4103\/1673-5374.143419","article-title":"Inflammatory response and neuronal necrosis in rats with cerebral ischemia","volume":"9","author":"Wu","year":"2014","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0115","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s12031-011-9496-4","article-title":"Specific role of tight junction proteins claudin-5, occludin, and ZO-1 of the blood-brain barrier in a focal cerebral ischemic insult","volume":"44","author":"Jiao","year":"2011","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0120","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s12276-018-0041-1","article-title":"Interleukin-1 receptor antagonist-mediated neuroprotection by umbilical cord-derived mesenchymal stromal cells following transplantation into a rodent stroke model","volume":"50","author":"Oh","year":"2018","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0125","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.5966\/sctm.2015-0023","article-title":"Intracarotid infusion of mesenchymal stem cells in an animal model of Parkinson's disease, focusing on cell distribution and neuroprotective and behavioral effects","volume":"4","author":"Cerri","year":"2015","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0130","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0361-9230(03)00043-1","article-title":"Facilitation of drug entry into the CNS via transient permeation of blood brain barrier: laboratory and preliminary clinical evidence from bradykinin receptor agonist, Cereport","volume":"60","author":"Borlongan","year":"2003","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0135","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ddtec.2016.07.007","article-title":"Ultrasound-mediated drug delivery to the brain: principles, progress and prospects","volume":"20","author":"Dasgupta","year":"2016","journal-title":"Drug Discov Today Technol"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0140","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/WNR.0b013e32835f8acb","article-title":"Intravenous mannitol does not increase blood-brain barrier permeability to inert dyes in the adult rat forebrain","volume":"24","author":"Chen","year":"2013","journal-title":"Neuroreport"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0145","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neulet.2013.08.058","article-title":"Mannitol enhances therapeutic effects of intra-arterial transplantation of mesenchymal stem cells into the brain after traumatic brain injury","volume":"554","author":"Okuma","year":"2013","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0150","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00018-013-1397-y","article-title":"Temozolomide down-regulates P-glycoprotein in human blood-brain barrier cells by disrupting Wnt3 signaling","volume":"71","author":"Riganti","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0155","doi-asserted-by":"crossref","first-page":"8904","DOI":"10.1038\/ncomms9904","article-title":"Wnt\/beta-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance","volume":"6","author":"Wickstrom","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2015.02.002","article-title":"Overcoming the blood-brain tumor barrier for effective glioblastoma treatment","volume":"19","author":"van Tellingen","year":"2015","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0165","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/978-1-60761-938-3_23","article-title":"Blood-brain barrier disruption in the treatment of brain tumors","volume":"686","author":"Blanchette","year":"2011","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0170","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.3892\/mmr.2015.3754","article-title":"Combination of the multipotent mesenchymal stromal cell transplantation with administration of temozolomide increases survival of rats with experimental glioblastoma","volume":"12","author":"Bryukhovetskiy","year":"2015","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0175","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.bbrc.2018.02.149","article-title":"Additional increased effects of mannitol-temozolomide combined treatment on blood-brain barrier permeability","volume":"497","author":"Choi","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0180","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/01.STR.20.1.84","article-title":"Reversible middle cerebral artery occlusion without craniectomy in rats","volume":"20","author":"Longa","year":"1989","journal-title":"Stroke"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0185","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1161\/01.STR.20.10.1383","article-title":"Photochemical stroke model: flunarizine prevents sensorimotor deficits after neocortical infarcts in rats","volume":"20","author":"De Ryck","year":"1989","journal-title":"Stroke"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0190","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1161\/01.STR.17.6.1304","article-title":"Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats","volume":"17","author":"Bederson","year":"1986","journal-title":"Stroke"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0195","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0361-9230(02)00962-0","article-title":"Examination of sensorimotor performance following middle cerebral artery occlusion in rats","volume":"59","author":"Reglodi","year":"2003","journal-title":"Brain Res Bull"},{"issue":"5 Pt 2","key":"10.1016\/j.jcyt.2018.04.004_bib0200","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1523\/JNEUROSCI.15-05-03863.1995","article-title":"Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test","volume":"15","author":"Olsson","year":"1995","journal-title":"J Neurosci"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0205","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/2040-7378-2-13","article-title":"Functional assessments in the rodent stroke model","volume":"2","author":"Schaar","year":"2010","journal-title":"Exp Transl Stroke Med"},{"issue":"Suppl. 1","key":"10.1016\/j.jcyt.2018.04.004_bib0210","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1089\/neu.2007.9994","article-title":"Guidelines for the management of severe traumatic brain injury. II. Hyperosmolar therapy","volume":"24","author":"Bratton","year":"2007","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0215","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.brainres.2008.05.080","article-title":"Mannitol enhances delivery of marrow stromal cells to the brain after experimental intracerebral hemorrhage","volume":"1224","author":"Seyfried","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0220","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1161\/01.STR.29.12.2631","article-title":"Mannitol at clinical concentrations activates multiple signaling pathways and induces apoptosis in endothelial cells","volume":"29","author":"Malek","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0225","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1038\/jcbfm.2008.40","article-title":"Combined therapeutic strategy using erythropoietin and mesenchymal stem cells potentiates neurogenesis after transient focal cerebral ischemia in rats","volume":"28","author":"Esneault","year":"2008","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0230","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1460-9568.2011.07733.x","article-title":"Transplantation of Flk-1+ human bone marrow-derived mesenchymal stem cells promotes angiogenesis and neurogenesis after cerebral ischemia in rats","volume":"34","author":"Bao","year":"2011","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0235","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1479-5876-8-63","article-title":"Adipose-derived mesenchymal stem cells markedly attenuate brain infarct size and improve neurological function in rats","volume":"8","author":"Leu","year":"2010","journal-title":"J Transl Med"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0240","doi-asserted-by":"crossref","first-page":"6206","DOI":"10.2174\/1381612823666170913164738","article-title":"The transport mechanism of extracellular vesicles at the blood-brain barrier","volume":"23","author":"Matsumoto","year":"2017","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0245","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1007\/s11095-014-1593-y","article-title":"Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio","volume":"32","author":"Yang","year":"2015","journal-title":"Pharm Res"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0250","doi-asserted-by":"crossref","first-page":"74537","DOI":"10.18632\/oncotarget.12902","article-title":"Intravenous administration of xenogenic adipose-derived mesenchymal stem cells (ADMSC) and ADMSC-derived exosomes markedly reduced brain infarct volume and preserved neurological function in rat after acute ischemic stroke","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0255","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/scrt428","article-title":"Microvesicles derived from human Wharton's Jelly mesenchymal stromal cells ameliorate renal ischemia-reperfusion injury in rats by suppressing CX3CL1","volume":"5","author":"Zou","year":"2014","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0260","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/stem.1409","article-title":"MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles","volume":"31","author":"Xin","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0265","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1038\/jcbfm.2013.152","article-title":"Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats","volume":"33","author":"Xin","year":"2013","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0270","doi-asserted-by":"crossref","first-page":"33038","DOI":"10.1038\/srep33038","article-title":"Microvesicles from brain-extract-treated mesenchymal stem cells improve neurological functions in a rat model of ischemic stroke","volume":"6","author":"Lee","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0275","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1080\/14653240310003026","article-title":"Adipose-derived adult stem cells: isolation, characterization, and differentiation potential","volume":"5","author":"Gimble","year":"2003","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0280","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2174\/157488810791268564","article-title":"Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine","volume":"5","author":"Salgado","year":"2010","journal-title":"Curr Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0285","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nn.3109","article-title":"Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models","volume":"15","author":"Bai","year":"2012","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0290","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nm.1905","article-title":"Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production","volume":"15","author":"Nemeth","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.jcyt.2018.04.004_bib0295","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.it.2006.10.004","article-title":"Angiopoietins: a link between angiogenesis and inflammation","volume":"27","author":"Fiedler","year":"2006","journal-title":"Trends Immunol"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324918305085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324918305085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:35:37Z","timestamp":1761442537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324918305085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S1465324918305085"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2018.04.004","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The combination of mannitol and temozolomide increases the effectiveness of stem cell treatment in a chronic stroke model","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2018.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}